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Summary
We recently showed that alkaptonuria (AKU) is caused
by loss-of-function mutations in the homogentisate 1,2
dioxygenase gene (HGO). Herein we describe haplotype
and mutational analyses of HGO in seven new AKU
pedigrees. These analyses identified two novel single-
nucleotide polymorphisms (INV431ArG and
INV1118ArG) and six novel AKU mutations (INV1-
1GrA, W60G, Y62C, A122D, P230T, and D291E),
which further illustrates the remarkable allelic hetero-
geneity found in AKU. Reexamination of all 29 muta-
tions and polymorphisms thus far described in HGO
shows that these nucleotide changes are not randomly
distributed; the CCC sequence motif and its inverted
complement, GGG, are preferentially mutated. These
analyses also demonstrated that the nucleotide substi-
tutions in HGO do not involve CpG dinucleotides,
which illustrates important differences between HGO
and other genes for the occurrence of mutation at specific
short-sequence motifs. Because the CCC sequencemotifs
comprise a significant proportion (34.5%) of all mutated
bases that have been observed in HGO, we conclude
that the CCC triplet is a mutational hot spot in HGO.
Introduction
Alkaptonuria (AKU; MIM 203500), the first disorder to
be interpreted as an inborn error of metabolism (Garrod
1902, 1908), is a rare disease in which homogentisate,
an intermediary product in the phenylalanine catabolic
pathway, cannot be further metabolized and causes ho-
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mogentisic aciduria, ochronosis, and arthritis (La Du
1995). Patients with AKU are deficient for homogentis-
ate dioxygenase (HGO; EC 1.13.11.5) (La Du et al.
1958), the enzyme mediating the conversion of homo-
gentisate to maleylacetoacetate (Knox and Edwards
1955). We recently cloned the human HGO gene and
demonstrated that patients with AKU are homozygous
or compound heterozygous for loss-of-function muta-
tions in HGO (Ferna´ndez-Can˜o´n et al. 1996). A total
of 17 different AKU mutations have been described thus
far (Ferna´ndez-Can˜o´n et al. 1996; Gehrig et al. 1997;
Beltra´n-Valero de Bernabe´ et al. 1998; Higashino et al.
1998), most of which are missense mutations changing
amino acid residues that are conserved between human
and other species. Only threemutations (P230S, V300G,
and M368V) have been found in more than one patient.
In addition to the AKU mutations, a number of poly-
morphisms have been encountered within the human
HGO gene (Granadino et al. 1997; Beltra´n-Valero de
Bernabe´ et al. 1998). The analysis of the haplotypic as-
sociation of these polymorphic markers in the AKU
chromosomes has been very useful for investigating the
history of the AKU mutations. These analyses suggested
that the most prevalent AKUmutations, P230S, V300G,
and M368V, are not recurrent mutations but instead are
probably old mutations that were introduced in Europe
with the founder populations and spread throughout
western Europe with the different migrations.
Herein we report the results of mutation and poly-
morphism analyses of the HGO gene in seven novel,
unrelated AKU pedigrees. These analyses resulted in an
identification of novel AKU mutations and HGO poly-
morphisms that prompted us to reexamine all the avail-
able HGO mutation and polymorphism data, searching
for base motifs that could be preferred targets for mu-
tation. We propose, on the basis of these studies, that
the CCC motif is a mutational hot spot in HGO.
Patients, Material, and Methods
Patients
Seven AKU pedigrees that had not been reported pre-
viously were included in our studies. The condition of
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Table 1
HGO Mutations Identified in Patients with AKU
Mutation
Mutation
Type Nucleotide Change
Amino Acid Change/
Predicted Consequence
No. (Origin)
of Families
Patient Number
(AKU Chromosome)
INV1-1GrA Splice site c183-1GrA (exon 2) Aberrant splicing 1 (Poland) 22 (a)
W60G Missense c345TrG (exon 4) Trp60Gly 1 (USA) 23 (b)
Y62C Missense c352ArG (exon 4) Tyr62Cys 1 (France) 20 (a, b)
A122D Missense c532CrA (exon 6) Ala122Asp 1 (Netherlands) 25 (a)
P230T Missense c855CrA (exon 10) Pro230Thr 1 (Spain) 18 (b)
D291E Missense c1040CrA (exon 11) Asp291Glu 1 (Spain) 21 (a)
M368Va Missense c1269ArG (exon 13) Met368Val 4 (2 Spain, 1 USA,
and 1 Netherlands)
18 (a), 24 (a, b),
23 (a), and 25 (b)
a The M368V mutation was described elsewhere in three patients with AKU (Beltra´n-Valero de Bernabe´ et al. 1998).
the probands in these families was diagnosed as AKU
on the basis of clinical and radiological examinations
and routine analyses for homogentisic aciduria. Three
of the pedigrees were from Spain and one each from
Poland, the U.S.A., France, and The Netherlands. DNA
samples were obtained from peripheral blood lympho-
cytes of the patients and their family members by use of
standard methods. Blood was collected from the patients
and their relatives after we obtained informed consent.
In one Spanish pedigree, only the children of the proband
were available for these studies.
Mutation Screening
The 14 exons of HGO were amplified from genomic
DNA by use of specific primers derived from the 5′ and
3′ intronic sequences (Beltra´n-Valero de Bernabe´ et al.
1998). SSCP analyses were performed, and any exons
presenting band shifts were subsequently sequenced.
Briefly, for SSCP analysis, amplification was performed
in a total volume of 10 ml containing 100 ng of genomic
DNA; 12.5 pmol of each primer; 1 U of Taq polymerase
(Perkin-Elmer Cetus); 250 mM dATP, dGTP, and dTTP;
10 mM dCTP; 1 mCi of [a-32P]-dCTP at 300 Ci/mmol;
1.5 mM MgCl2; 50 mM KCl; and 10 mM Tris-HCl at
pH 8.3. PCR conditions were 1 cycle at 94C for 2 min,
followed by 30 cycles at 94C for 1 min, 60C for 1
min, and 72C for 1 min and 1 cycle at 72C for 3 min.
Samples were resolved on 8% and/or 10% nondena-
turing polyacrylamide gels and exposed to Kodak
X–Omat AR film with intensifying screens at70C for
2–10 h.
Analysis of HGO Polymorphisms
We performed PCR analysis of polymorphisms at the
HGO-1 (D3S4496), HGO-2 (D3S4497), and HGO-3
(D3S4556) microsatellites by use of total human ge-
nomic DNA, as described elsewhere (Beltra´n-Valero de
Bernabe´ et al. 1998). The HGO intragenic dimorphic
markers IVS235A/T, c407T/A, IVS525T/C, and
IVS646C/A were characterized by SSCP analysis, as
described elsewhere (Beltra´n-Valero de Bernabe´ et al.
1998).
DNA Sequencing
For each patient, the HGO exons selected were am-
plified from genomic DNA by use of specific primers
derived from the 5′ and 3′ intronic sequences, as de-
scribed elsewhere (Beltra´n-Valero de Bernabe´ et al.
1998). We used theWizard PCR Preps DNA purification
system (Promega) to purify the corresponding PCR
products and used a dye terminator cycle sequencing kit
(Perkin-Elmer) to perform direct sequencing of them.
Sequences were resolved on an ABI PRISM 377 auto-
matic sequencer.
Statistical Methods
To calculate the expected number of mutations
associated with the CCC sequence motif, we as-
sumed equal mutability of all nucleotides in the HGO
sequence. If one of the four nucleotides underlined
(NNNCCCNNN) was mutated at one specific CCC se-
quence motif, we considered the mutation to be asso-
ciated to a CCC motif. Therefore, for a given gene se-
quence, the total number of potential mutations
associated to CCC sequence motifs was determined by
multiplying by four the number of CCC triplets within
the gene sequence. In case of overlapping CCC triplets,
the nucleotides that were potential mutation sites for
both CCC triplets were counted only once. The expected
frequency of mutation at the sites of CCC triplets is
calculated as the number of potential mutations at these
sites divided by the total number of nucleotides in the
sequence. A similar calculation was performed to deter-
mine the expected frequency of mutation at CpG din-
ucleotides. The observed frequency of mutation at CCC
and at CpG was contrasted against the expected distri-
bution under the hypothesis of no association (Fleiss
1981). All P values reported are two tailed.
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Table 2
Novel Polymorphic Markers within the HGO Gene
Marker Type HET PIC Primer Sequences, Forward/Reverse Allele Frequency
INV4 31A/G Single base change
(intron 4)
.036 .035 ACTCTAAGGCTTGTATATCTTGTAT/
TTCCAATGACCATGGTATTC
A
G
.98
.02
INV11 18A/G Single base change
(intron 11)
.033 .032 TGGCACGGGAATTATACACCC/
CTGTGGATCCCTCCCACCCAAGCG
A
G
.98
.02
References for Links among Databases
The AKU gene, HGO, codes for homogentisate 1,2
dioxygenase (HGO, EC 1.13.11.5). The complete nu-
cleotide sequences for the human HGO gene (54,363
bp) and its transcript (1,715 bp) have been deposited
under accession numbers AF000573 and AF045167, re-
spectively. All the information about the coagulation fac-
tor VIII gene (F8C) was obtained from the haemophilia
A database HAMSTeRS.
Results
Novel AKU Mutations
A total of 13 AKU chromosomes in seven AKU ped-
igrees were screened for mutations in HGO. Seven of
the 13 AKU chromosomes carry mutations that are de-
scribed here for the first time. Five of these novel AKU
mutations (W60G, Y62C, A122D, P230T, and D291E)
are missense mutations, and one (IVS1-1GrA) is a
splice-site mutation. With the exception of W60G,
which was detected only by DNA sequencing, the novel
mutations were detected by SSCP and characterized by
sequencing. Five of the 13 AKU chromosomes from the
seven novel AKU pedigrees carry the M368V mutation,
a relatively frequent mutation that was encountered pre-
viously in three AKU chromosomes from France and
Germany (Beltra´n-Valero de Bernabe´ et al. 1998). In
only 1 of 13 AKU chromosomes were we not able to
identify the mutation, although the 14 HGO exons and
their intronic flanking sequences were sequenced in both
strands. None of the six novel AKU mutations were
encountered in a sample of 100 normal chromosomes
from the Spanish population, indicating that these nu-
cleotide changes do not represent frequent HGO poly-
morphisms. Table 1 summarizes the mutations encoun-
tered in this sample of 13 AKU chromosomes.
Novel HGO Polymorphisms
During our search for mutations in the AKU chro-
mosomes, we discovered two single-nucleotide substi-
tutions that are HGO polymorphisms. These single-nu-
cleotide polymorphisms are located in intron 4
(IVS431A/G) and intron 11 (IVS1118A/G) (table 2).
Prevalence of M368V and Founder Effects
The results of the analyses of the haplotypic associ-
ations of the HGO polymorphic markers IVS235A/T,
c407T/A, HGO-3, HGO-1, IVS525T/C, IVS646C/
A, and HGO-2 in the 13 novel AKU chromosomes in-
cluded in this report are depicted in table 3. This analysis
shows that all five M368V AKU mutations are associ-
ated with the HGO-A haplotype, which was previously
found to be associated with the M368V mutation in
three other AKU chromosomes from France and Ger-
many (Beltra´n-Valero de Bernabe´ et al. 1998). These
results strongly suggest that the prevalence of the
M368V mutation is a consequence of a founder effect,
which reinforces the concept that M368V is an old mu-
tation that has spread throughout Europe with the dif-
ferent migrations.
Mutational Hot Spots in HGO
Gene mutations are largely related to nucleotide se-
quences. We have used the MUTPRED program devel-
oped by Cooper and Krawczak (1990) to predict the
spectrum of point mutations in HGO. MUTPRED gen-
erates a mutability profile and is based on nearest neigh-
bor–dependent mutation rates estimated from 7,500
single–base pair substitutions from the human gene mu-
tation database.
Analysis of the mutability spectrum of HGO gener-
ated by MUTPRED showed that 3 (W60G, W97G, and
R225H) of the 16 missense mutations in HGO would
have been predicted by the program. R225H is the only
mutation thus far encountered inHGO that is associated
with a CpG dinucleotide.
Among the HGO mutations that were not predicted
by MUTPRED, P230T is a novel mutation that results
from a CrA transversion at HGO nucleotide position
c855 in exon 10. The P230T mutation is interesting
because nucleotide position c855 has been shown else-
where to be involved in a single–base pair change that
causes the P230S mutation (Ferna´ndez-Can˜o´n et al.
1996). Therefore, the same HGO nucleotide has been
involved in two independent AKU mutations. In one
case, the cytosine in position c855 mutates to adenine,
generating the P230T mutation, whereas in the second
case, the same cytosine in P230S mutates to thymine to
originate the P230Smutation. Because it is very unlikely
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Table 3
HGO Haplotypes Associated to the AKU Mutations
MUTATION
ASSOCIATED POLYMORPHISMS
PATIENTaIVS235A/T c407T/A IVS431A/G HGO-3 HGO-1 IVS525T/C IVS646A/C IVS1118A/G HGO-2
INV1-1GrA A T A 201 161 T C A 181 PL/22/a
W60G A/T T A 195 161 T C/A A 181/179 US/23/b
Y62C T T A 191 161 T A A 179 FR/20/a
T T A 191 161 T A A 179 FR/20/b
A122D A T/A A 195 161 T C G 183 NL/25/a
P230T A T A 199 161 T C A 181 SP/18/b
D291E A T A 193/189 161 T C A 175 SP/21/a
M368V A T A 199 161 T C A 181 SP/18/a
A T/A A 195 161 T C A 181 NL/25/b
A/T T A 195 161 T C/A A 181/179 US/23/a
A T A 195 161 T C A 179 SP/24/a
A T A 195 161 T C A 179 SP/24/b
Unknown A A A 195 161 T C G 189 PL/22/b
a Country of origin/patient number/AKU chromosome. PL  Poland, US  United States, FR  France, NL  The Netherlands, SP  Spain.
Table 4
Single-Nucleotide Substitutions at CCC Trinucleotides in HGO
Mutation
Mutation
Type
Original Sequence
(5′r3′) Coding Strand
Mutated Sequence
(5′r3′) Coding Strand Nucleotide Change
D153G Missense ATGGGGACT ATGGGGGCT c625A Gr
G161R Missense GAAAGGGAA GAAAAGGAA c648G Ar
P230S Missense GATACCCAT GATATCCAT c855C Tr
P230T Missense GATACCCAT GATAACCAT c855C Ar
IVS9-56G Ar Intron CATGGGCAT CATGGACAT c817-56G Ar
IVS9-17G Ar Intron TTTGGGTTA TTTAGGTTA c817-17G Ar
F10fs Frameshift TTTGGGAAT TTTATTGAAT c198GG ATTr
G152fs Frameshift GATGGGGACT GATGGGGGACT c621insG
IVS646C Ar Polymorphism AGGGCTTTTa AGGGATTTT c60146C Ar
IVS1118A Gr Polymorphism TGTAGGGGCa TGTGGGGGC c104618A Gr
NOTE.—The nucleotides that are found mutated at the CCC sequence motifs are underlined.
a It is unknown which of the two alleles of the polymorphism corresponds to the original sequence.
that this coincidence occurred by chance, we considered
the possibility that position c855 is a mutational hot
spot in HGO and searched for sequence motifs associ-
ated with this position. Position c855 lies within a triplet
of cytosines. Interestingly, 34.5% (10/29) of the nucle-
otide changes (mutations and polymorphisms) thus far
characterized in HGO lie within, or are adjacent to,
a triplet of cytosines or its inverted complement
(NNNCCCNNN [the nucleotides that are found mu-
tated at the CCC sequence motifs are underlined]) (table
4). These figures significantly exceed the 9% frequency
of mutations at these sites that would be expected on
the basis of the frequency of CCC/GGG trinucleotides
in HGO, suggesting that the CCC motif is a mutational
hot spot (table 5).
Discussion
AKU presents a remarkable allelic heterogeneity.
Twenty-three different mutations have been identified in
a total of 29 AKU pedigrees, which, when one considers
that 52% of these patients are homozygous, results in
almost one novel mutation per patient. In addition to
the 23 AKU mutations, we have identified six single-
nucleotide polymorphisms in theHGO gene. Therefore,
adding mutations and polymorphisms, we have char-
acterized, thus far, 29 different nucleotide changes in the
human HGO gene.
Gene mutation is a highly nonrandom process. In eu-
karyotic genomes, ∼30% of the point mutations occur
in CpG dinucleotides (Cooper et al. 1995). In fact, CpG
was first found to be a hot spot for mutation in the
factor VIII gene (F8C) and subsequently in a wide range
of different human genes (Youssoufian et al. 1986). We
have analyzed the HGO sequence in search of muta-
tional hot spots. Notably, these analyses showed that,
whereas a CpG was implicated in only 1 of the 29 nu-
cleotide changes in HGO, in 10 of them, the mutated
position lies within, or is adjacent to, a triplet of cyto-
sines or its inverted complement. This suggests that the
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Table 5
Mutations at CpG and CCC Motifs in HGO and F8C Genes
GENE
SEQUENCE
(BP)a
NO. AT
CPG
(CPG/KB)
MUTATION AT CPG
(%)b
NO. AT
CCC
(CCC/KB)
MUTATION AT CCC
(%)b
Expected Observed Expected Observed
HGO 3,609 34 (9.4) .5/29 (1.8) 1/29 (3.4) 95 (26.3) 2.6/29 (9) 10/29 (34.5)c
F8C 13,191 96 (7.3) 9/678 (1.4)
to 5/333 (1.4)
304/678 (44.8)c
to 65/333 (19.5)
272 (20.6) 48/678 (7.1)
to 24/333 (7.1)
87/678 (12.8)d
to 46/333 (13.8)
a The HGO sequence included in these analyses corresponds to the 14 exons and the flanking intronic sequences that are
amplified by use of the primer pairs described by us elsewhere (Beltra´n-Valero de Bernabe´ et al. 1998). The F8C sequence
also corresponds to the exons and the flanking intronic sequences and was obtained from GenBank under accession numbers
M88628–M88648.
b Some mutations in HGO have been encountered in more than one AKU patient. However, they were considered only
once in these analyses, since the characterization of the HGO polymorphisms suggests that their prevalence is a consequence
of a founder effect. Nucleotide changes at F8C (point mutations, splice mutations, polymorphisms, and deletions/insertions
of !3 nucleotides) are described in the F8C mutation database (http://europium.mrc.rpms.ac.uk). Because of the difficulty in
determining whether the F8C mutations that have been encountered more than once are recurrent or identical-by-descent,
we considered the two extreme situations: (1) All F8C mutations are recurrent, and, therefore, we have included all described
cases of F8C mutations ( ); and (2) None of the F8C mutations that have been encountered more than once aren  678
recurrent mutations, their prevalence being due to founder effects. In this case, only different F8C mutations were considered
( ). Expected frequencies were determined as indicated in Material and Methods.n  333
c P ! .001
d Some CCC triplets overlap with CpG dinucleotides in F8C, which may cause overestimation of mutations at CCC or
CpG.
CCC motif, like the CpG dinucleotide in F8C, is a mu-
tational hot spot in HGO (table 4).
The increased frequency of mutation at the CCC se-
quence motif in HGO is not a consequence of an ab-
normally high content in these triplets. The HGO gene
sequence that we have analyzed, including the sequences
of exons and their flanking introns, is 3,609 nt long and
contains 34 CpG dinucleotides and 95 CCC trinucleo-
tides. These numbers are similar to those observed in
other human genes, such as F8C (Youssoufian et al.
1986), in which the CpG dinucleotides are preferred sites
of mutation. InHGO, the frequency of mutation at CpG
dinucleotides does not differ from the random expec-
tation. Instead, it is the frequency of mutation at CCC
triplets that is significantly increased, compared with
that expected to occur randomly (table 5).
Because most of the single-nucleotide changes that we
have encountered in HGO are AKU mutations, it could
be argued that the increased frequency of mutations ob-
served at CCC (or GGG) motifs could result from a
detection bias. To test this possibility, we considered all
potential mutations in the HGO coding region. This
analysis showed that single-nucleotide changes at CCC
(or GGG) motifs do not cause missense or nonsense
mutations more frequently than do single-nucleotide
changes at other, non-CCC motifs. Similarly, we ruled
out the possibility that CCC motifs are preferentially
associated to evolutionary conserved amino acid posi-
tions (identities comparing the human [HGO] and As-
pergillus [HmgA] amino acid sequences).
Since it is known that the distribution of CpG mu-
tation in the human genome may be nonrandom, the
fact that CpG dinucleotides are not mutational hot spots
inHGO should not be surprising. It has been postulated
that this nonrandom distribution of CpGmutational hot
spots relates to differences in cytosine methylation in the
germ line in different regions of the genome (Reitsma et
al. 1993). Whether the low frequency of CpG mutation
in HGO compared with F8C can be attributed to the
lower degree of methylation in the CpG dinucleotides
in this gene versus those in F8C is unknown.
The frequency of nucleotide changes at positions
within, or adjacent to, CCC trinucleotides is not signif-
icantly increased in other genes with CCC triplet content
similar to that of HGO, which suggests, as in the case
of the CpG dinucleotides, that the CCC putative hot
spots may not have a random distribution in the human
genome (table 5).
CpG dinucleotides are not the only sequence motif
that has been reported to be a mutational hot spot.
Among the other examples in which specific short-se-
quence motifs are associated to mutational hot spots,
the most fascinating is the somatic hypermutation of
antibody genes (reviewed by Green et al. 1998). In this
case, mutations are limited to the DNA in and around
the immunoglobulin genes’ V regions, within which
there are mutational hot spots that have been defined as
three- to four-base sequences such as AGC and TAC and
their inverted repeats (Smith et al. 1996), with the most
prominent motif being RGYW or AGY, where R 
, , and . Although lit-purine Y  pyrimidine W  A or T
tle is known about the molecular mechanisms that are
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responsible for this hypermutation process, it is thought
that the process may be linked to the elevated transcrip-
tional rate of these genes and that the hypermutation
rate may result both from a sequence motif prone to
mutate and from some interference with the nucleotide
repair machinery (Green et al. 1998). Similarly, in Es-
cherichia coli, it has been postulated that the overabun-
dance of mutations induced by alkylating agents at GGG
sequence motifs may relate to structural features that
make them more refractory to excision or repair mech-
anisms (Burns et al. 1988). It is unknown whether the
overabundance of mutations at CCC motifs in HGO is
the consequence of a higher mutation rate at these sites
or of a deficient repair.
The mutation and polymorphism data for the human
HGO gene that we have presented here clearly indicate
that mutation in CCC triplets occurs in HGO at a sig-
nificantly increased frequency in comparison with that
expected to occur randomly. Of all nucleotide changes
thus far reported in HGO, 34.5% affect CCC trinucle-
otides, and, notably, one of these sequence motifs has
been involved in the generation of two different AKU
mutations. Therefore, we propose that the CCC se-
quence motifs are mutational hot spots in the human
HGO gene. The data presented also illustrate the dif-
ferences between genes for the occurrence of mutations
at specific short-sequence motifs. These differences may
be a consequence of structural (e.g., sequence modifi-
cation or chromatin organization) and functional (e.g.,
transcriptional rate) features of the individual genes. An
additional series of 13 novel AKU mutations, from Fin-
land and Slovakia, has been reported at various meet-
ings. Analysis of the sequences associated to these ad-
ditional mutations fully supports our conclusion, stated
earlier, that the CCC trinucleotides are mutational hot
spots in HGO.
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